Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Platelets and autoimmunity.
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
The genetics of multiple sclerosis: review of current and emerging candidates.
Targeting of aquaporin 4 into lipid rafts and its biological significance.
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
Brain MRI findings in Japanese patients with clinically isolated syndrome.
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Targeting erythropoietin for chronic neurodegenerative diseases.
The risks for falls and fractures in multiple sclerosis.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
Sex Disparities in Neuro-Ophthalmologic Disorders.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »